Table 3.
Progression free and overall survival by patient characteristics.
| Characteristic | No. of patients | PFS | OS | ||
|---|---|---|---|---|---|
|
|
|
||||
| Median (months) | P | Median (months) | P | ||
| Age group, years | |||||
| < 50 | 139 | 39.3 | 0.0843 | N/A | 0.0004 |
| 50–59 | 102 | 29.5 | 70.3 | ||
| 60–69 | 102 | 34.2 | N/A | ||
| 70+ | 74 | 25.3 | 52.2 | ||
| Race | |||||
| White | 359 | 33.1 | 0.6665 | 71.2 | 0.1964 |
| Black | 26 | 27.2 | 55.1 | ||
| Other | 32 | 39.3 | 82.4 | ||
| GOG performance status | |||||
| 0 | 193 | 43.3 | 0.0037 | N/A | 0.0002 |
| 1 | 200 | 29.0 | 64 | ||
| 2 | 24 | 27.4 | 55.1 | ||
| Histology | |||||
| Serous | 265 | 32.9 | 0.0376 | 71.2 | < .0001 |
| Endometrioid | 43 | 37.2 | N/A | ||
| Clear cell | 29 | 26.2 | 43.3 | ||
| Mucinous | 16 | 12.9 | 19.6 | ||
| Mixed epithelial | 35 | 56.7 | 79.8 | ||
| Other | 29 | 40.4 | 65.1 | ||
| Tumor grade | |||||
| 1 | 60 | 54.4 | 0.1311 | N/A | 0.2444 |
| 2 | 129 | 32.1 | 66.9 | ||
| 3 | 228 | 31.9 | 70.3 | ||
| Initial disease distribution | |||||
| MD | 59 | 47.6 | 0.0139 | N/A | 0.0044 |
| APD | 260 | 34.8 | 79.8 | ||
| UAD | 98 | 23.9 | 56.1 | ||
Abbreviations: PFS, progression free survival; OS, overall survival; GOG, Gynecologic Oncology Group; MD, minimal disease; APD, abdominal peritoneal disease; UAD, upper abdominal disease.